Table 3.
Variable | Univariate analysis |
Multivariate analysis |
|||||
---|---|---|---|---|---|---|---|
HR6 | 95%CIb | P | HR | 95%CI | P | ||
Preoperative Child-Pugh stage | 0.330 | ||||||
A | 0.401 | 0.105–1.524 | 0.180 | ||||
B | 0.615 | 0.277–1.367 | 0.233 | ||||
C | |||||||
Postoperative Child-Pugh stageb | <0.001 | 0.001 | |||||
A | 0.109 | 0.039–0.301 | <0.001 | 0.023 | 0.003–0.167 | <0.001 | |
B | 0.201 | 0.086–0.468 | <0.001 | 0.141 | 0.039–0.507 | 0.003 | |
C | |||||||
Change of Child-Pugh stageb | 0.009 | 0.027 | |||||
Down | 0.174 | 0.057–0.531 | 0.002 | 0.542 | 0.198–0.731 | 0.011 | |
Unchanged | 0.308 | 0.115–0.829 | 0.020 | 0.645 | 0.293–0.879 | 0.036 | |
Elevated | |||||||
Change of Child-Pugh scoreb | Down | 0.198 | 0.098–0.398 | <0.001 | 0.085 | 0.018–0.398 | 0.002 |
Unchanged/elevated | |||||||
Postoperative grading of ascitesb | 0/1 | 0.226 | 0.115–0.441 | <0.001 | 0.541 | 0.137–2.130 | 0.379 |
2/3 | |||||||
Response to TIPSa | <0.001 | 0.248 | |||||
CR | 0.120 | 0.049–0.296 | <0.001 | 1.316 | 0.205–8.441 | 0.772 | |
PR | 0.359 | 0.149–0.868 | 0.023 | 2.434 | 0.623–9.515 | 0.201 | |
AR | |||||||
BCLC classificationa | A/B | 0.466 | 0.212–1.025 | 0.049 | 64,709 | 0.001–79,050 | 0.910 |
C/D | |||||||
PVTTa | No | 0.353 | 0.159–0.785 | 0.011 | 0.001 | 0.001–3303 | 0.914 |
Yes | |||||||
Number of tumors | Single | 0.421 | 0.182–0.971 | 0.043 | 0.822 | 0.225–3.004 | 0.767 |
Multiple | |||||||
Intrahepatic local treatmentc | Yes | 0.302 | 0.142–0.642 | 0.002 | 0.680 | 0.181–2.558 | 0.568 |
No | |||||||
AFPa | <400 | 0.341 | 0.174–0.672 | 0.002 | 0.277 | 0.113–0.679 | 0.005 |
≥400 | |||||||
MELDa | <15 | 1.701 | 0.662–4.370 | 0.270 | 0.971 | 0.312–3.024 | 0.960 |
≥15 | |||||||
Age | <60 | 1.387 | 0.722–2.666 | 0.326 | 1.394 | 0.606–3.205 | 0.434 |
≥60 |
The p-value with bold indicates a statistically significant difference.
The response to TIPS: complete response (CR), no clinically detectable ascites with or without diuretics and sodium limitation; partial response (PR), clinically detectable ascites without the requirement for further paracentesis; or absent response (AR), development of large amount of ascites after TIPS; BCLC, Barcelona Clinic Liver Cancer; PVTT, portal vein tumor thrombosis; AFP, alpha fetoprotein; MELD, model of end stage liver disease; IQR, interquartile range; CI. Confidence interval.
At one month after TIPS, the grading of ascites, Child-Pugh stage, and Child-Pugh score were reassessed.
Including transarterial chemoembolization and ablation.